THE Federal Court of Australia has
found that weight loss company
SensaSlim Australia Pty Ltd, now in
liquidation, engaged in misleading
or deceptive conduct by failing to
disclose Peter Foster’s involvement
in its franchise system’s disclosure
document.
The Court also found that the
company engaged in misleading
conduct with regards to the role of
SensaSlim’s officers, Peter O’Brien
and Michael Boyle, the “worldwide
clinical trial” of the solution and the
earning potential of its franchises.
Justice Yates described Foster
as a puppeteer in his judgement,
and said the failure to disclose his
involvement was deliberate.
The Australian Competition &
Consumer Commission started
proceedings against the company in
July 2011.
To read more, CLICK HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 10 Apr 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Apr 14
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
THE Pharmaceutical Society of Australia (PSA) has unveiled a comprehensive membership package designed to provide robust support for credentialed pharmacists throughout their professional journey.
MEDICAL research produces better outcomes when people with lived experience are involved in the process, according to Breast Cancer Network Australia (BCNA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.